Gaps in evidence in the treatment of prevalent patients with pulmonary arterial hypertension at intermediate risk: An expert consensus.
Manzi G, Benza RL, Argiento P, Casu G, Corda M, Correale M, D'Alto M, Galgano G, Garascia A, Ghio S, Gomberg-Maitland M, Mulé M, Paciocco G, Papa S, Prati D, Preston IR, Raineri C, Romeo E, Scelsi L, Stolfo D, Vitulo P, White RJ, Badagliacca R, Vizza CD.
Manzi G, et al. Among authors: romeo e.
Vascul Pharmacol. 2024 Sep 10;157:107432. doi: 10.1016/j.vph.2024.107432. Online ahead of print.
Vascul Pharmacol. 2024.
PMID: 39265796
Review.